EXHIBIT 23.1

                        CONSENT OF INDEPENDENT AUDITORS

The Board of Directors
Calypte Biomedical Corporation

    We consent to the incorporation by reference in the registration statement
(No. 333-16769) on Form S-8, the registration statement (No. 333-38417) on
Form S-3, the registration statement (No. 333-66765) on Form S-3, the
registration statement (No. 333-75239) on Form S-3, the registration statement
(No. 333-32246) on Form S-3, and in the registration statement (No. 333-54316)
on Form S-2 of Calypte Biomedical Corporation of our reports dated February 23,
2001 relating to the consolidated balance sheets of Calypte Biomedical
Corporation and subsidiary as of December 31, 2000 and 1999, and the related
consolidated statements of operations, stockholders' equity and cash flows for
each of the years in the three-year period ended December 31, 2000 and the
related schedule, which reports appear in the December 31, 2000 annual report on
Form 10-K of Calypte Biomedical Corporation.

    The accompanying consolidated financial statements have been prepared
assuming that the Company will continue as a going concern. As discussed in
Note 1 to the consolidated financial statements, the Company has suffered
recurring losses from operations and has an accumulated deficit that raise
substantial doubt about its ability to continue as a going concern. Management's
plans in regard to these matters are also described in Note 1. The consolidated
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.

                                          KPMG LLP

San Francisco, California
February 23, 2001